Monopar Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MNPR and other ETFs, options, and stocks.

About MNPR

Monopar Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. engages in building a drug development pipeline through the licensing and acquisition of oncology therapeutics in late preclinical and clinical development stages. Its product pipeline includes Validive, Camsirubicin and MNPR-101. 

CEO
Chandler Drew Robinson
CEOChandler Drew Robinson
Employees
10
Employees10
Headquarters
Wilmette, Illinois
HeadquartersWilmette, Illinois
Founded
2014
Founded2014
Employees
10
Employees10

MNPR Key Statistics

Market cap
18.89M
Market cap18.89M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
13.26K
Average volume13.26K
High today
$1.52
High today$1.52
Low today
$1.52
Low today$1.52
Open price
$1.52
Open price$1.52
Volume
3.00
Volume3.00
52 Week high
$5.74
52 Week high$5.74
52 Week low
$1.39
52 Week low$1.39

MNPR Earnings

-$0.22
-$0.15
-$0.07
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 11, Pre-Market
ActualExpected Nov 11, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.